0,833  0,002  Phospholipase C inhibitor
0,830  0,004  Antineoplastic (solid tumors)
0,811  0,006  Carcinogenic
0,799  0,002  Hematopoietic
0,809  0,015  Apoptosis agonist
0,789  0,005  Bone diseases treatment
0,786  0,004  Tumour necrosis factor alpha release inhibitor
0,780  0,003  Septic shock treatment
0,775  0,004  CTGF expression inhibitor
0,748  0,005  Platelet antagonist
0,738  0,004  Immunosuppressant
0,742  0,013  Teratogen
0,732  0,013  Embryotoxic
0,718  0,007  Analeptic
0,711  0,001  Triose-phosphate isomerase inhibitor
0,728  0,020  Caspase 9 stimulant
0,725  0,026  Antiinflammatory
0,702  0,009  Mutagenic
0,702  0,010  Respiratory analeptic
0,693  0,001  Inosine monophosphate dehydrogenase 1 inhibitor
0,690  0,009  Antithrombotic
0,682  0,006  Immunomodulator
0,677  0,005  Cardioprotectant
0,669  0,004  Anesthetic general
0,657  0,001  Phosphofructokinase-1 inhibitor
0,666  0,016  GST A substrate
0,641  0,004  Sulfotransferase substrate
0,632  0,004  Glutathione S-transferase substrate
0,626  0,004  Chelator
0,621  0,005  Wound healing agent
0,615  0,002  NADH dehydrogenase inhibitor
0,617  0,004  Aldehyde dehydrogenase inhibitor
0,607  0,002  Calcium channel activator
0,604  0,004  Bone formation stimulant
0,622  0,027  Antiarthritic
0,598  0,003  DNA polymerase I inhibitor
0,606  0,010  Antiosteoporotic
0,599  0,011  Antiparasitic
0,594  0,008  DNA synthesis inhibitor
0,593  0,017  Immunostimulant
0,573  0,002  Antineoplastic, alkylator
0,571  0,001  UDP-glucose 4-epimerase inhibitor
0,583  0,015  Radioprotector
0,562  0,005  Non-steroidal antiinflammatory agent
0,564  0,010  Antipyretic
0,562  0,014  AR expression inhibitor
0,550  0,008  RNA-directed DNA polymerase inhibitor
0,544  0,005  Transcription factor STAT inhibitor
0,546  0,009  Antimitotic
0,536  0,002  Carbamoyl phosphate synthetase inhibitor
0,554  0,021  Antihypercholesterolemic
0,536  0,005  Radiosensitizer
0,530  0,003  Glutamate dehydrogenase inhibitor
0,528  0,004  Sepsis treatment
0,543  0,021  Antineoplastic (myeloid leukemia)
0,520  0,003  Porphobilinogen synthase inhibitor
0,514  0,005  Antidiabetic (type 1)
0,529  0,021  Cytotoxic
0,508  0,002  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,507  0,006  Transcription factor STAT3 inhibitor
0,522  0,024  Antiallergic
0,500  0,001  Adenylate kinase inhibitor
0,496  0,001  Biliverdin reductase inhibitor
0,524  0,034  Antibacterial
0,484  0,002  Fumarate hydratase inhibitor
0,482  0,002  Toll-Like receptor 4 antagonist
0,502  0,023  Ulceration
0,479  0,001  Growth factor receptor-bound protein 2 antagonist
0,498  0,020  Lipoprotein disorders treatment
0,486  0,010  Interleukin agonist
0,489  0,014  Eye irritation, high
0,483  0,011  Antihelmintic
0,485  0,018  Antineoplastic (non-Hodgkin's lymphoma)
0,470  0,006  Adenylate cyclase inhibitor
0,468  0,006  Alpha-N-acetylglucosaminidase inhibitor
0,469  0,013  Myocardial infarction treatment
0,460  0,004  Expectorant
0,473  0,023  Antioxidant
0,458  0,013  Platelet aggregation inhibitor
0,454  0,009  Carcinogenic, group 3
0,447  0,002  Mannose-6-phosphate isomerase inhibitor
0,482  0,039  Antipruritic, allergic
0,491  0,049  TNF expression inhibitor
0,457  0,015  Antineoplastic (endocrine cancer)
0,452  0,016  Psychostimulant
0,431  0,008  Antiviral (Influenza)
0,445  0,023  Proliferative diseases treatment
0,423  0,004  Antiinfertility, female
0,440  0,024  Antiprotozoal (Leishmania)
0,428  0,012  Antiviral (HIV)
0,440  0,024  Chemopreventive
0,416  0,007  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,442  0,033  Antifungal
0,410  0,009  Antineoplastic antimetabolite
0,404  0,004  Purinergic P2 antagonist
0,462  0,062  Antidiabetic
0,462  0,062  Cyclophilin D inhibitor
0,441  0,042  Angiogenesis inhibitor
0,413  0,021  Vasodilator
0,396  0,004  Histidine decarboxylase inhibitor
0,420  0,029  Antineoplastic (multiple myeloma)
0,395  0,004  Aminoacyl-tRNA synthetase inhibitor
0,393  0,002  Antihelmintic (Fasciola)
0,422  0,033  Antineoplastic (pancreatic cancer)
0,389  0,001  Toll-Like receptor 4 agonist
0,391  0,004  Sphingosine 1-phosphate receptor 2 agonist
0,392  0,006  Cystic fibrosis treatment
0,388  0,006  Renal failure treatment
0,381  0,001  Purinergic P2Y1 antagonist
0,388  0,008  Alkylator
0,384  0,005  Hexokinase inhibitor
0,376  0,003  Sphingomyelinase inhibitor
0,384  0,015  GST M1-1 substrate
0,370  0,003  Argininosuccinate synthase inhibitor
0,413  0,047  Cholesterol antagonist
0,368  0,002  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,387  0,024  Vascular (periferal) disease treatment
0,387  0,024  Angiogenesis stimulant
0,378  0,017  Antiviral (Herpes)
0,368  0,008  Acute respiratory distress syndrome (ARDS) treatment
0,375  0,018  Skin irritative effect
0,364  0,008  Antiviral (Hepatitis B)
0,361  0,006  Cholesterol synthesis inhibitor
0,348  0,002  Adenylate cyclase stimulant
0,405  0,058  Toll-Like receptor agonist
0,371  0,026  Antineoplastic (small cell lung cancer)
0,360  0,015  Melanin inhibitor
0,354  0,010  Interleukin 6 antagonist
0,398  0,056  Vasodilator, peripheral
0,352  0,012  GST P1-1 substrate
0,346  0,009  Antineoplastic (bone cancer)
0,368  0,031  Hypolipemic
0,337  0,004  Potassium channel large-conductance Ca-activated activator
0,369  0,038  Sensitization
0,336  0,011  Diabetic nephropathy treatment
0,377  0,052  FMO1 substrate
0,338  0,014  Acaricide
0,334  0,016  Antialcoholic
0,320  0,005  Catenin beta inhibitor
0,312  0,001  Acyl-CoA dehydrogenase inhibitor
0,337  0,028  Antineoplastic (bladder cancer)
0,312  0,005  Alcohol dehydrogenase inhibitor
0,321  0,015  c-Src kinase inhibitor
0,309  0,004  Ornithine carbamoyltransferase inhibitor
0,310  0,008  Antiviral (Poxvirus)
0,304  0,003  Sphingosine 1-phosphate receptor 3 agonist
0,301  0,001  Glucose-6-phosphate isomerase inhibitor
0,315  0,015  Protein kinase stimulant
0,341  0,043  Antineoplastic (osteosarcoma)
0,343  0,046  Chemoprotective
0,329  0,039  Acute neurologic disorders treatment
0,334  0,048  UGT2B4 substrate
0,288  0,003  Purinergic P2Y antagonist
0,287  0,004  Transcription factor STAT6 inhibitor
0,303  0,020  Antiviral (Hepatitis)
0,326  0,044  Cardiodepressant
0,286  0,004  Antiviral (Influenza B)
0,343  0,062  Hepatic disorders treatment
0,285  0,005  Potassium channel (Ca-activated) activator
0,281  0,002  Purinergic P2X1 antagonist
0,284  0,007  Cyclooxygenase 3 inhibitor
0,339  0,061  Apoptosis antagonist
0,352  0,076  Transcription factor NF kappa B inhibitor
0,313  0,037  Cyclic AMP phosphodiesterase inhibitor
0,300  0,027  Antimutagenic
0,292  0,022  Anesthetic
0,312  0,045  Pyruvate kinase inhibitor
0,272  0,005  Coagulant
0,275  0,012  Cell wall synthesis inhibitor
0,291  0,033  Antihypotensive
0,258  0,003  Phosphoglycerate kinase inhibitor
0,256  0,003  Inosine monophosphate dehydrogenase inhibitor
0,254  0,003  Glycine receptor antagonist
0,255  0,004  Phosphorylase inhibitor
0,261  0,013  Age-related macular degeneration treatment
0,252  0,006  NAD(P)H dehydrogenase (quinone) inhibitor
0,250  0,005  Chronic obstructive bronchitis treatment
0,314  0,068  NOS3 expression inhibitor
0,249  0,007  Antimetabolite
0,281  0,040  Platelet adhesion inhibitor
0,250  0,009  Toll-Like receptor 2 antagonist
0,246  0,006  Arachidonic acid antagonist
0,241  0,003  Purinergic P2X2 antagonist
0,243  0,005  Carcinogenic, group 2A
0,246  0,008  Selectin antagonist
0,244  0,007  Growth stimulant
0,313  0,077  Vasodilator, coronary
0,273  0,037  Hepatoprotectant
0,293  0,059  Cardiotonic
0,238  0,010  Carbonic anhydrase XIII inhibitor
0,227  0,001  Purinergic receptor agonist
0,227  0,001  Purinergic P2 agonist
0,266  0,040  DNA methylase inhibitor
0,249  0,023  Antiviral (Hepatitis C)
0,306  0,082  Antihypertensive
0,228  0,004  Heat shock protein 70 antagonist
0,228  0,005  Interferon agonist
0,279  0,057  Antineoplastic (lymphoma)
0,235  0,015  Neurotrophic factor
0,228  0,008  HIV-1 integrase (Strand Transfer) inhibitor
0,239  0,020  Carcinogenic, group 1
0,237  0,019  Toll-Like receptor antagonist
0,221  0,004  Sphingosine 1-phosphate receptor 5 agonist
0,215  0,001  Purinergic P2X agonist
0,272  0,059  Cytostatic
0,215  0,003  Glutamate (mGluR6) antagonist
0,224  0,013  Antischistosomal
0,219  0,010  GABA C receptor antagonist
0,219  0,011  Antiviral (CMV)
0,218  0,010  Mucolytic
0,232  0,029  Skin whitener
0,203  0,001  Purinergic P2Y agonist
0,210  0,008  Sphingosine 1-phosphate receptor 5 antagonist
0,205  0,006  DOPA decarboxylase inhibitor
0,207  0,009  HIV-1 integrase (3'-Processing) inhibitor
0,205  0,010  Creatine kinase inhibitor
0,262  0,067  Antineoplastic (liver cancer)
0,202  0,007  Sphingosine 1-phosphate receptor 2 antagonist
0,286  0,092  Prostate cancer treatment
0,202  0,009  Sphingosine 1-phosphate receptor 4 antagonist
0,203  0,013  DNA directed RNA polymerase inhibitor
0,222  0,034  Antiviral (Influenza A)
0,201  0,014  Breast cancer-resistant protein inhibitor
0,204  0,019  Microtubule formation inhibitor
0,199  0,016  Menstruation disorders treatment
0,187  0,006  Anabolic
0,191  0,011  Folate antagonist
0,207  0,027  Protein-tyrosine phosphatase 1B inhibitor
0,185  0,007  Antidote, mercury
0,186  0,010  Keratolytic
0,185  0,008  CDC25A inhibitor
0,207  0,031  Alkaline phosphatase inhibitor
0,229  0,055  Abortion inducer
0,182  0,013  DNA repair enzyme inhibitor
0,171  0,003  Adenine nucleotide translocase inhibitor
0,170  0,002  Purinergic P2Y2 antagonist
0,254  0,086  Renal disease treatment
0,202  0,036  Tubulin antagonist
0,172  0,006  Glutamate (mGluR7) agonist
0,209  0,044  Cytidine deaminase inhibitor
0,178  0,015  AMP-activated protein kinase stimulant
0,200  0,037  UGT2B10 substrate
0,180  0,017  Aldehyde dehydrogenase substrate
0,221  0,059  Nitric-oxide synthase stimulant
0,196  0,034  Aldose reductase substrate
0,290  0,129  Atherosclerosis treatment
0,251  0,091  CYP2C19 substrate
0,171  0,012  Transcription factor NF kappa B stimulant
0,163  0,006  Protein 50S ribosomal subunit inhibitor
0,167  0,010  Tocolytic
0,163  0,005  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,191  0,033  Raynaud's phenomenon treatment
0,208  0,051  Src kinase inhibitor
0,176  0,020  Vanilloid 1 agonist
0,159  0,007  Autotaxin inhibitor
0,156  0,004  Purinergic P2T antagonist
0,167  0,016  Ca2+-transporting ATPase inhibitor
0,176  0,026  GABA C receptor agonist
0,233  0,084  Antineoplastic (sarcoma)
0,199  0,051  Antihelmintic (Nematodes)
0,153  0,005  Uterine relaxant
0,193  0,047  Amylase inhibitor
0,280  0,135  Histamine release inhibitor
0,188  0,044  Corneal wound healing stimulator
0,234  0,090  DNA damaging
0,202  0,059  Antipruritic, non-allergic
0,146  0,006  Hypercalcemia treatment
0,191  0,051  Antirickettsial
0,146  0,006  D-Ala-D-Ala ligase inhibitor
0,190  0,051  Protein-tyrosine phosphatase inhibitor
0,146  0,009  Sphingosine 1-phosphate receptor 4 agonist
0,166  0,030  Beta amyloid protein antagonist
0,162  0,026  Contraceptive female
0,181  0,045  Antidiarrheal
0,139  0,004  Lysophosphatidic acid 2 receptor antagonist
0,168  0,034  Antihemorrhagic
0,146  0,013  Ribonucleotide reductase inhibitor
0,175  0,044  SULT1A3 substrate
0,176  0,045  Hemostatic
0,249  0,119  Interleukin 2 agonist
0,139  0,013  Ribonucleoside-diphosphate reductase inhibitor
0,144  0,018  UGT2B11 substrate
0,141  0,015  Lanosterol 14 alpha demethylase inhibitor
0,156  0,036  Carcinogenic, group 2B
0,193  0,073  Antiviral (Ebola)
0,133  0,017  Glutathione S-transferase inhibitor
0,140  0,026  GABA C receptor rho-1 antagonist
0,132  0,019  Carbonic anhydrase V inhibitor
0,176  0,062  Muscular dystrophy treatment
0,117  0,004  Lysophosphatidic acid 3 receptor antagonist
0,116  0,004  Thymidylate synthase inhibitor
0,170  0,058  UGT2B9 substrate
0,220  0,109  Antineoplastic (ovarian cancer)
0,135  0,025  GST T1-1 substrate
0,123  0,014  Antiviral (Dengue virus)
0,120  0,013  Narcotic antagonist
0,230  0,123  FMO3 substrate
0,116  0,009  Cathepsin E inhibitor
0,109  0,003  Glutamate (mGluR8) agonist
0,215  0,110  UGT1A9 substrate
0,201  0,097  Peptidyltransferase inhibitor
0,123  0,019  Aminopeptidase I inhibitor
0,229  0,125  Antimycobacterial
0,108  0,004  AICAR transformylase inhibitor
0,118  0,014  Alcohol oxidase inhibitor
0,165  0,062  Phospholipase A2 inhibitor
0,104  0,003  Cholesterol absorption inhibitor
0,112  0,011  Androgen agonist
0,123  0,023  Ornithine decarboxylase inhibitor
0,124  0,025  Phosphodiesterase I inhibitor
0,127  0,029  Actinic keratosis treatment
0,251  0,153  GABA C receptor rho-3 antagonist
0,187  0,090  Neurotrophic factor enhancer
0,199  0,102  NOS2 expression inhibitor
0,098  0,003  Hypoxanthine phosphoribosyltransferase inhibitor
0,117  0,022  Glutamate decarboxylase inhibitor
0,100  0,006  Alpha-mannosidase inhibitor
0,168  0,076  Liver fibrosis treatment
0,093  0,001  Guanylate cyclase inhibitor
0,135  0,044  Aminopeptidase B inhibitor
0,144  0,053  Antihyperlipoproteinemic
0,215  0,125  5 Hydroxytryptamine uptake stimulant
0,182  0,093  Pneumotoxic
0,094  0,005  Antiviral (Hepatitis D)
0,095  0,007  Squalene synthetase inhibitor
0,169  0,081  Succinate dehydrogenase inhibitor
0,089  0,003  Uridine phosphorylase inhibitor
0,099  0,012  Antiviral (Parainfluenza)
0,093  0,007  Thymidine kinase inhibitor
0,118  0,031  Interleukin 12 antagonist
0,090  0,004  Geranyltranstransferase inhibitor
0,118  0,032  Paget's disease treatment
0,095  0,009  Sphingosine 1-phosphate receptor 3 antagonist
0,092  0,007  Anesthetic inhalation
0,151  0,067  Lipid peroxidase inhibitor
0,151  0,068  Hair growth stimulant
0,087  0,004  Purinergic P2Y12 antagonist
0,099  0,017  Estrogen agonist
0,174  0,092  UGT1A1 substrate
0,187  0,106  Antiglaucomic
0,107  0,026  Na+ K+ transporting ATPase inhibitor
0,082  0,001  Purinergic P2Y1 agonist
0,087  0,007  Mannosidase inhibitor
0,230  0,151  CYP3A4 substrate
0,089  0,011  Sphingosine kinase 2 inhibitor
0,100  0,022  Sphingosine 1-phosphate receptor antagonist
0,095  0,018  Phospholipase D inhibitor
0,090  0,012  Antiviral (Herpesvirus 3, Human)
0,094  0,018  ZAP-70 protein tyrosine kinase inhibitor
0,203  0,129  Tyrosine 3 hydroxylase inhibitor
0,232  0,158  Stroke treatment
0,089  0,015  SULT2A1 substrate
0,146  0,072  UGT2B15 substrate
0,183  0,110  UGT1A6 substrate
0,124  0,052  Excitatory amino acid transporter EAAC1 inhibitor
0,145  0,074  Genotoxic
0,076  0,005  Antibiotic Aminoglycoside-like
0,104  0,033  Antibiotic
0,195  0,125  5 Hydroxytryptamine release stimulant
0,091  0,025  Antidote, organophosphates
0,074  0,008  Purinergic P2X4 antagonist
0,150  0,085  Uterine stimulant
0,079  0,014  Lipocortins synthesis agonist
0,069  0,004  Vanilloid 3 antagonist
0,179  0,116  Antineoplastic (cervical cancer)
0,197  0,134  Flavin-containing monooxygenase substrate
0,063  0,001  Mannitol 2-dehydrogenase inhibitor
0,154  0,092  Aldehyde oxidase substrate
0,145  0,084  Interferon gamma antagonist
0,079  0,019  Potassium channel (Ca-activated) blocker
0,159  0,099  LDLR expression enhancer
0,126  0,066  Gastritis treatment
0,072  0,012  Adenosine deaminase inhibitor
0,118  0,059  Cystathionine beta-synthase inhibitor
0,062  0,004  Thymidine phosphorylase inhibitor
0,070  0,012  Fructose-1,6-bisphosphatase inhibitor
0,073  0,017  Sphingosine 1-phosphate receptor 1 antagonist
0,097  0,041  Antileprosy
0,082  0,027  Antiemphysemic
0,087  0,033  HIV-1 integrase inhibitor
0,068  0,014  Heparanase inhibitor
0,055  0,002  Glutamate (mGluR6) agonist
0,138  0,087  Acetylcholine M1 receptor antagonist
0,122  0,073  Antiviral (Papilloma)
0,053  0,004  Lysophosphatidic acid receptor 1 agonist
0,113  0,063  SULT1A1 substrate
0,068  0,020  Ryanodine receptor antagonist
0,060  0,013  Sphingosine 1-phosphate receptor 1 agonist
0,122  0,075  Antismoking
0,060  0,013  Glutamate (mGluR group III) antagonist
0,094  0,047  Antispirochetal
0,170  0,123  Aldehyde oxidase inhibitor
0,082  0,037  GABA B receptor agonist
0,062  0,017  Phosphate transporter inhibitor
0,061  0,016  Sphingosine 1-phosphate receptor agonist
0,050  0,007  Ceramide glucosyltransferase inhibitor
0,107  0,064  Ferrochelatase inhibitor
0,046  0,003  Vanilloid 2 agonist
0,075  0,033  CDC25B inhibitor
0,138  0,096  UGT2B7 substrate
0,044  0,003  Lysophosphatidic acid receptor 3 agonist
0,054  0,013  Membrane dipeptidase inhibitor
0,131  0,090  Peroxidase inhibitor
0,042  0,001  Methylmalonyl-CoA mutase inhibitor
0,133  0,093  Insulin secretagoues
0,043  0,004  Lysophosphatidic acid 1 receptor antagonist
0,061  0,023  Antibiotic Glycopeptide-like
0,115  0,078  Antifungal (Pneumocystis)
0,041  0,005  Inosine monophosphate dehydrogenase 2 inhibitor
0,065  0,029  Postmenopausal disorders treatment
0,103  0,068  Topoisomerase I inhibitor
0,048  0,014  RNA-directed RNA polymerase inhibitor
0,087  0,053  Vanilloid agonist
0,077  0,044  HIV-1 reverse transcriptase inhibitor
0,084  0,052  Thioredoxin reductase inhibitor
0,200  0,168  Antineoplastic (brain cancer)
0,070  0,038  Antihemophilic
0,039  0,007  Adenosine kinase inhibitor
0,053  0,022  Cytokine production stimulant
0,036  0,005  1,3-Beta-glucan synthase inhibitor
0,072  0,043  Carbonic anhydrase VA inhibitor
0,062  0,033  Carbonic anhydrase VB inhibitor
0,036  0,009  Adenosine A1 receptor agonist
0,140  0,113  Hearing loss treatment
0,041  0,014  HCV NS5B polymerase inhibitor
0,062  0,035  Sphingosine kinase inhibitor
0,052  0,026  Microtubule stabilization
0,036  0,010  Purinergic P2Y15 antagonist
0,070  0,044  Gaucher disease treatment
0,033  0,008  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,041  0,016  Sodium-dependent vitamin C transporter 2 inhibitor
0,165  0,141  Cardiovascular analeptic
0,031  0,007  Fructose-1,6-bisphosphatase 1 inhibitor
0,093  0,069  Phosphodiesterase 6D inhibitor
0,039  0,016  HMG CoA reductase inhibitor
0,048  0,025  Glutamate (mGluR group III) agonist
0,034  0,011  Protein 30S ribosomal subunit inhibitor
0,042  0,020  CF transmembrane conductance regulator antagonist
0,097  0,075  UGT2B1 substrate
0,050  0,029  Carnitine palmitoyltransferase 1B inhibitor
0,072  0,051  Glycine receptor agonist
0,154  0,134  Histone acetyltransferase inhibitor
0,021  0,001  Purinergic P2Y4 agonist
0,062  0,043  Antimycoplasmal
0,021  0,002  Purinergic P2Y2 agonist
0,069  0,051  Dysmenorrhea treatment
0,023  0,005  Telomerase stimulant
0,043  0,026  Sphingosine kinase 1 inhibitor
0,061  0,044  Corticotropin releasing factor 2 receptor antagonist
0,026  0,010  Vitamin D receptor antagonist
0,052  0,036  Aconitate hydratase inhibitor
0,059  0,045  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,158  0,143  Antineoplastic (non-small cell lung cancer)
0,200  0,186  Antineoplastic (breast cancer)
0,059  0,044  Potassium channel intermediate-conductance Ca-activated blocker
0,108  0,094  Antiprotozoal (Amoeba)
0,017  0,004  Purine nucleoside phosphorylase inhibitor
0,113  0,100  Antiprotozoal (Trichomonas)
0,032  0,022  Glutamate (mGluR3) agonist
0,087  0,077  Xanthine oxidase inhibitor
0,115  0,106  Psychosexual dysfunction treatment
0,039  0,030  Toll-Like receptor 2 agonist
0,160  0,152  VCAM1 expression inhibitor
0,079  0,071  Estrogen-related receptor beta agonist
0,040  0,032  Kainate receptor agonist
0,022  0,014  Corticosteroid-like
0,071  0,064  Antineoplastic antibiotic
0,033  0,025  Carnitine palmitoyltransferase 1 inhibitor
0,026  0,019  Sodium/glucose cotransporter 2 inhibitor
0,040  0,033  Hypogonadism treatment
0,016  0,009  N-Acetylated alpha-linked acidic dipeptidase inhibitor
0,083  0,078  Obsessive-compulsive disorder treatment
0,006  0,001  Purinergic P2Y6 agonist
0,051  0,046  Aminopeptidase microsomal inhibitor
0,032  0,027  Carnitine palmitoyltransferase inhibitor
0,041  0,037  Endothelin-converting enzyme inhibitor
0,057  0,052  Prostaglandin F2 alpha antagonist
0,025  0,022  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,136  0,134  Antineoplastic (glioblastoma multiforme)
0,032  0,029  Glutamate (mGluR4) agonist
0,043  0,041  Cholesterol esterase inhibitor
0,024  0,023  Sodium/glucose cotransporter inhibitor
0,031  0,030  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,018  0,017  Antibiotic Anthracycline-like

